The role of TRPC4 in PAH was investigated in a model of hypoxic PAH in which rats were pretreated with a vascular endothelial growth factor receptor 2 inhibitor, exposed to three weeks of hypoxia, and then returned to normoxia. This evidence concerns the gene KDR and pulmonary arterial hypertension.